tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

OTLK Stock Latest News

Navigating Trade Turbulence: Outlook Therapeutics’ Struggle with Global Trade Policies
Company AnnouncementsNavigating Trade Turbulence: Outlook Therapeutics’ Struggle with Global Trade Policies
12d ago
OTLK
Outlook Therapeutics Reports Q3 2025 Earnings and Milestones
PremiumCompany Announcements
Outlook Therapeutics Reports Q3 2025 Earnings and Milestones
13d ago
OTLK
Outlook Therapeutics reports Q3 adjusted EPS (44c) vs. (83c) last year
PremiumThe Fly
Outlook Therapeutics reports Q3 adjusted EPS (44c) vs. (83c) last year
13d ago
OTLK
OTLK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
OTLK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
16d ago
OTLK
Outlook Therapeutics Appoints New CEO Robert Charles Jahr
PremiumCompany Announcements
Outlook Therapeutics Appoints New CEO Robert Charles Jahr
2M ago
8K
OTLK
Outlook Therapeutics appoints Bob Jahr as CEO
PremiumThe FlyOutlook Therapeutics appoints Bob Jahr as CEO
2M ago
OTLK
Outlook Therapeutics announces SMC recommendation of LYTENAVA
Premium
The Fly
Outlook Therapeutics announces SMC recommendation of LYTENAVA
3M ago
OTLK
Outlook Therapeutics Launches LYTENAVA in Europe
Premium
Company Announcements
Outlook Therapeutics Launches LYTENAVA in Europe
3M ago
8K
OTLK
Outlook Therapeutics announces commercial launch of LYTENAVA in Germany, UK
PremiumThe Fly
Outlook Therapeutics announces commercial launch of LYTENAVA in Germany, UK
3M ago
OTLK
Outlook Therapeutics Announces New Stock and Warrant Offering
PremiumCompany Announcements
Outlook Therapeutics Announces New Stock and Warrant Offering
3M ago
8K
OTLK
Outlook Therapeutics 9.3M share Spot Secondary priced at $1.40
PremiumThe Fly
Outlook Therapeutics 9.3M share Spot Secondary priced at $1.40
3M ago
OTLK
Outlook Therapeutics Reports Improved Financials Amid Challenges
PremiumCompany Announcements
Outlook Therapeutics Reports Improved Financials Amid Challenges
3M ago
OTLK
Outlook Therapeutics announces common stock, warrants offering
PremiumThe FlyOutlook Therapeutics announces common stock, warrants offering
3M ago
OTLK
Outlook Therapeutics price target lowered to $8 from $10 at Guggenheim
Premium
The Fly
Outlook Therapeutics price target lowered to $8 from $10 at Guggenheim
3M ago
OTLK
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
INM
XLO
Outlook Therapeutics reports Q2 EPS (40c), consensus (55c)
PremiumThe Fly
Outlook Therapeutics reports Q2 EPS (40c), consensus (55c)
3M ago
OTLK
Outlook Therapeutics Approves Retention Incentive for CFO
PremiumCompany Announcements
Outlook Therapeutics Approves Retention Incentive for CFO
5M ago
8K
OTLK
Outlook Therapeutics announces acceptance of BLA by U.S. FDA for ONS-5010
PremiumThe Fly
Outlook Therapeutics announces acceptance of BLA by U.S. FDA for ONS-5010
5M ago
OTLK
Outlook Therapeutics files to sell 21.72M shares of common stock for holders
PremiumThe Fly
Outlook Therapeutics files to sell 21.72M shares of common stock for holders
5M ago
OTLK
Outlook Therapeutics management to meet virtually with BTIG
PremiumThe FlyOutlook Therapeutics management to meet virtually with BTIG
5M ago
OTLK
Outlook Therapeutics Issues Convertible Note to Avondale
Premium
Company Announcements
Outlook Therapeutics Issues Convertible Note to Avondale
6M ago
8K
OTLK
Outlook Therapeutics files to sell 7.07M shares of common stock for holders
Premium
The Fly
Outlook Therapeutics files to sell 7.07M shares of common stock for holders
6M ago
OTLK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >